Furthermore, as a 2018 presentation made clear about HSAT (the abbreviation now used by many to clarify that sleep itself is not actually measured):
(Underlining is in the original)Respected Chicago dude wrote:
. . . Home Sleep Apnea Testing (HSAT)
• Best for diagnosis in high suspicion patients
• Does not rule out disease
• Best device is not known
• Not as simple as it looks
. . . 2007 Recommendations from the AASM on HSAT for OSA
. . . • High pretest probability of moderate to severe OSA
– Without comorbid medical conditions or suspected comorbid sleep disorders
. . . • Not recommended for general screening of asymptomatic patients . . .
From a 2018 slide presentation: Technologies for the Diagnosis and Monitoring of Sleep Disordered Breathing, Neil Freedman, MD. -- https://www.fda.gov/media/112614/download
So the confusion by payors is based on the misunderstanding that the high value of HST for getting obviously symptomatic OSA patients to PAP quickly also means that HST must have some value in screening to rule out disease. This is not the case. It is a serious point with serious life-and-death consequences. Especially is this the case for people with high likelihood of central issues or sleep issues beyond simple obstruction of any sort, which HST is not designed to help find.
I get that their, ahem, heart may be in the right place, but pretending HST screens in a way that it rules out any benefit from PAP for any given patient is just wrong, wrong, wrong. In my not-so-humble opinion.
End of my rant. In this thread, anyway.
